IL28B Polymorphism Is Not Associated With HCV Protease Diversity in Patients Co-Infected With HIV and HCV Treated With Pegylated Interferon and Ribavirin

類似資料

• Impact of interferon-ribavirin treatment on hepatitis C virus (HCV) protease quasispecies diversity in HIV- and HCV-coinfected patients
  著者:: Chary, Aarthi, 等
  出版事項: (2010)
• Immune Biomarker Differences and Changes Comparing HCV Mono-Infected, HIV/HCV Co-Infected, and HCV Spontaneously Cleared Patients
  著者:: Kushner, Lauren E., 等
  出版事項: (2013)
• HIV/Hepatitis C Virus–Coinfected Virologic Responders to Pegylated Interferon and Ribavirin Therapy More Frequently Incur Interferon-Related Adverse Events Than Nonresponders Do
  著者:: Osinusi, Anu, 等
  出版事項: (2010)
• HIV/HCV-Coinfected Natural Viral Suppressors have better virologic responses to PEG-IFN and Ribavirin than ARV-treated HIV/HCV Patients
  著者:: SIDIQUE, Nadeera, 等
  出版事項: (2011)
• ITPA Gene Polymorphisms Significantly Affect Hemoglobin Decline and Treatment Outcomes in Patients Coinfected With HIV and HCV
  著者:: Osinusi, Anu, 等
  出版事項: (2012)